Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10021


Purpose:

The purpose of this study is to assess the feasibility of conducting a large hospital based case control study of the role of dioxins and dioxinlike polychlorinated dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs).


Criteria:

Inclusion Criteria: - Patients with Soft tissue sarcoma at MSKCC are eligible for this study if they meet the following criteria: - Between 18 and 79 years of age - were diagnosed within the previous 6 months with primary soft tissue sarcoma of one of the following histologic subtypes: liposarcoma, leiomyoscaroma, MFH, or synovial sarcoma - are enrolled in protocol 02-060 ("Novel Biochemical and Molecularr Determinants for Soft Tissue Sarcoma"; PI, Dr. Samuel Singer) - controls will be eligibile for this study if they meet the following criteria - are b/w 18-79 years of age - have no prior history of cancer (other than non melanoma skin cancer) Exclusion Criteria: - Individuals will be excluded if they - are unable to sign informed consent for medical or other reasons - do not speak english


NCT ID:

NCT00611078


Primary Contact:

Principal Investigator
Lawrence Engel, Ph.D.
Memorial Sloan-Kettering Cancer Center


Backup Contact:

N/A


Location Contact:

New York, New York 10021
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 20, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.